Immunology
A focus on TYK2.
Research into selective inhibitors for inflammatory and autoimmune disease, including the JH2 pseudokinase domain.
Explore TYK2 researchDifferent diseases. A shared discovery approach.
Our platform is disease-agnostic by design. Current research interests span immunology, virology and neurology, from hit identification through lead optimization.
Virology
Influenza A and B.
A multi-target approach to neuraminidase inhibition, connecting computational screening with laboratory investigation.
Explore influenza researchNeurology
Neurodegenerative disease.
Biocentric’s published pipeline includes an Alzheimer’s disease research interest. The target has not been publicly disclosed.
Discuss a collaborationResearch scope, made clear.
| Area | Indication | Target | Public evidence |
|---|---|---|---|
| Immunology | Anti-inflammatory research | TYK2 | Screening and benchmark case studies |
| Virology | Influenza A / B | Neuraminidase | Case study and linked publication |
| Neurology | Alzheimer’s disease | Undisclosed | Research interest in published pipeline |
Research descriptions do not establish clinical efficacy, safety or regulatory status. No clinical-stage completion is asserted here.
A better next step for your research.
Bring your target, your challenge, or your next idea. Let’s explore it together.